Literature DB >> 16189654

Deep venous thrombosis in a patient with Behçet's disease and homozygous prothrombin (factor II) G20210A mutation on oral contraceptive pills.

Imad Uthman1, Zaher Otrock, Ali Taher.   

Abstract

Behçet's disease (BD) is a multisystemic disease of unknown aetiology characterized by chronic relapsing oral aphthous lesions, genital ulcers, uveitis, and vasculopathy of both arteries and veins of all sizes. We present the case of a female patient, with BD on oral contraceptive pills, who sustained deep venous thrombosis of the long saphenous vein. The patient was found to be a carrier of a homozygous mutation of the prothrombin (factor II) G20210A gene. Our case suggests that a thrombophilia work-up may be warranted in BD patients, especially young women before they are prescribed oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189654     DOI: 10.1007/s00296-005-0048-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Thrombosis associated with the prothrombin G-->A20210 mutation in Behçet's disease.

Authors:  C Salvarani; K Calamia; M Silingardi; A Ghirarduzzi; I Olivieri
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

Review 2.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

3.  High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?

Authors:  A Taher; I Khalil; A Shamseddine; F El-Ahdab; A Bazarbachi
Journal:  Thromb Haemost       Date:  2001-08       Impact factor: 5.249

4.  Association of factor V Leiden and prothrombin gene mutation with Behçet's disease.

Authors:  U Tursen; T I Kaya; G Eskandari; O Gunduz; M Yazar; G Ikizoglu; U Atik
Journal:  Arch Dermatol Res       Date:  2001-11       Impact factor: 3.017

Review 5.  The prothrombin 20210 G to A variation and thrombosis.

Authors:  R M Bertina
Journal:  Curr Opin Hematol       Date:  1998-09       Impact factor: 3.284

6.  Letter from Lebanon.

Authors:  I Uthman; K Kassak; R Sanjakdar; V Mendelek; A F Masri; F W Nasr
Journal:  Br J Rheumatol       Date:  1997-07

7.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.

Authors:  Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfons López-Soto; Ricard Cervera; Antoni Ordinas; Miguel Ingelmo; Joan-Carles Reverter
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

8.  A patient homozygous for a mutation in the prothrombin gene 3'-untranslated region associated with massive thrombosis.

Authors:  T E Howard; M Marusa; C Channell; A Duncan
Journal:  Blood Coagul Fibrinolysis       Date:  1997-07       Impact factor: 1.276

9.  Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.

Authors:  P B Toydemir; A H Elhan; A Tükün; R Toydemir; A Gürler; A Tüzüner; I Bökesoy
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

10.  High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.

Authors:  I Martinelli; E Sacchi; G Landi; E Taioli; F Duca; P M Mannucci
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

View more
  1 in total

Review 1.  Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review.

Authors:  Sherif Elkattawy; Ramez Alyacoub; Kerry S Singh; Hardik Fichadiya; William Kessler
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.